Concepedia

Marie Thérèse Closon-Dejardin

MT

3

Publications

299

Citations

3

H-Index

2001

Active since

Affiliations

Institut Jules Bordet(Current)

Marie Thérèse Closon-Dejardin is an author at Institut Jules Bordet specializing in cancer therapeutics, radiation oncology, and breast cancer.

Top concepts

Publications per year

2001–2008

3

Publications

3

Phase III Trial Comparing Two Dose Levels of Epirubicin Combined With Cyclophosphamide With Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer

Martine Piccart, Angelo Di Leo, M. Beauduin et al. · Journal of Clinical Oncology · 2001 · 163 citations

HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

Angelo Di Leo, Denis Larsimont, David Gancberg et al. · Annals of Oncology · 2001 · 107 citations

, , +8

Long-Term Benefit of High-Dose Epirubicin in Adjuvant Chemotherapy for Node-Positive Breast Cancer: 15-Year Efficacy Results of the Belgian Multicentre Study

Evandro de Azambuja, Marianne Paesmans, M. Beauduin et al. · Journal of Clinical Oncology · 2008 · 29 citations · Full text

Rows per page

1–3 of 3